Compared to EVs released from inactivated cells, EVs secreted from cells exposed to IL15 displayed enhanced tumor targeting ability and cytotoxicity in glioblastoma, breast, and thyroid cancer cells, while the viability of kidney epithelial cells was unchanged 117. This evidence concerns the gene IL15 and glioblastoma.